Transcatheter transseptal mitral valve implantation with Edwards SAPIEN 3: the first experience of a single center

In recent years, there has been a clear trend towards increased mitral bioprosthetic valve surgery in comparison to mechanical prostheses [1]. According to the ESC Guidelines mitral bioprostheses are recommended for patients > 70 years old or those with a life expectancy lower than the presumed d...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Paweł Kralisz, Marek Frank, Bożena Sobkowicz, Slawomir Dobrzycki, Tomasz Hirnle
Formato:	article
Lenguaje:	EN
Publicado:	Termedia Publishing House 2021
Materias:	Medicine R
Acceso en línea:	https://doaj.org/article/e15ced6a59154f7f8ffe7b360897eb9c
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:e15ced6a59154f7f8ffe7b360897eb9c
record_format	dspace
spelling	oai:doaj.org-article:e15ced6a59154f7f8ffe7b360897eb9c2021-12-02T18:55:08ZTranscatheter transseptal mitral valve implantation with Edwards SAPIEN 3: the first experience of a single center1734-93381897-429510.5114/aic.2021.104776https://doaj.org/article/e15ced6a59154f7f8ffe7b360897eb9c2021-03-01T00:00:00Zhttps://www.termedia.pl/Transcatheter-transseptal-mitral-valve-implantation-with-Edwards-SAPIEN-3-the-first-experience-of-a-single-center,35,43645,1,1.htmlhttps://doaj.org/toc/1734-9338https://doaj.org/toc/1897-4295In recent years, there has been a clear trend towards increased mitral bioprosthetic valve surgery in comparison to mechanical prostheses [1]. According to the ESC Guidelines mitral bioprostheses are recommended for patients > 70 years old or those with a life expectancy lower than the presumed durability of the bioprosthesis (class IIa/C). Importantly, the guidelines also recognize the prominence of quality of life after cardiosurgery and focus on patients’ preferences (class Ic), especially if long-term anticoagulation is nonoptimal (class Ic) [2]. Structural deterioration of mitral bioprostheses (structural valve deterioration – SVD) is the main limitation for their use. The average lifespan of a bioprosthetic valve is estimated at 16 years and the reoperation due to SVD affects as many as 75% of patients after a 20-year follow-up [3, 4]. Reoperation is usually associated with high risk of complications and mortality [5, 6].Paweł KraliszMarek FrankBożena SobkowiczSlawomir DobrzyckiTomasz HirnleTermedia Publishing HousearticleMedicineRENAdvances in Interventional Cardiology, Vol 17, Iss 1, Pp 105-108 (2021)
institution	DOAJ
collection	DOAJ
language	EN
topic	Medicine R
spellingShingle	Medicine R Paweł Kralisz Marek Frank Bożena Sobkowicz Slawomir Dobrzycki Tomasz Hirnle Transcatheter transseptal mitral valve implantation with Edwards SAPIEN 3: the first experience of a single center
description	In recent years, there has been a clear trend towards increased mitral bioprosthetic valve surgery in comparison to mechanical prostheses [1]. According to the ESC Guidelines mitral bioprostheses are recommended for patients > 70 years old or those with a life expectancy lower than the presumed durability of the bioprosthesis (class IIa/C). Importantly, the guidelines also recognize the prominence of quality of life after cardiosurgery and focus on patients’ preferences (class Ic), especially if long-term anticoagulation is nonoptimal (class Ic) [2]. Structural deterioration of mitral bioprostheses (structural valve deterioration – SVD) is the main limitation for their use. The average lifespan of a bioprosthetic valve is estimated at 16 years and the reoperation due to SVD affects as many as 75% of patients after a 20-year follow-up [3, 4]. Reoperation is usually associated with high risk of complications and mortality [5, 6].
format	article
author	Paweł Kralisz Marek Frank Bożena Sobkowicz Slawomir Dobrzycki Tomasz Hirnle
author_facet	Paweł Kralisz Marek Frank Bożena Sobkowicz Slawomir Dobrzycki Tomasz Hirnle
author_sort	Paweł Kralisz
title	Transcatheter transseptal mitral valve implantation with Edwards SAPIEN 3: the first experience of a single center
title_short	Transcatheter transseptal mitral valve implantation with Edwards SAPIEN 3: the first experience of a single center
title_full	Transcatheter transseptal mitral valve implantation with Edwards SAPIEN 3: the first experience of a single center
title_fullStr	Transcatheter transseptal mitral valve implantation with Edwards SAPIEN 3: the first experience of a single center
title_full_unstemmed	Transcatheter transseptal mitral valve implantation with Edwards SAPIEN 3: the first experience of a single center
title_sort	transcatheter transseptal mitral valve implantation with edwards sapien 3: the first experience of a single center
publisher	Termedia Publishing House
publishDate	2021
url	https://doaj.org/article/e15ced6a59154f7f8ffe7b360897eb9c
work_keys_str_mv	AT pawełkralisz transcathetertransseptalmitralvalveimplantationwithedwardssapien3thefirstexperienceofasinglecenter AT marekfrank transcathetertransseptalmitralvalveimplantationwithedwardssapien3thefirstexperienceofasinglecenter AT bozenasobkowicz transcathetertransseptalmitralvalveimplantationwithedwardssapien3thefirstexperienceofasinglecenter AT slawomirdobrzycki transcathetertransseptalmitralvalveimplantationwithedwardssapien3thefirstexperienceofasinglecenter AT tomaszhirnle transcathetertransseptalmitralvalveimplantationwithedwardssapien3thefirstexperienceofasinglecenter
_version_	1718377298630017024

Transcatheter transseptal mitral valve implantation with Edwards SAPIEN 3: the first experience of a single center

Ejemplares similares